GLS2 and cancer: In recent years, l-glutaminase production using microbial sources (Actinomycetes, bacteria, and fungi) has increased due to its effective role as an economical agent in the food industry, cancer therapy, and in biosensors as a monitoring agent to estimate l-glutamine level [22].